Bradford C. Connett Sells 4,036 Shares of Henry Schein, Inc. (NASDAQ:HSIC) Stock

Henry Schein, Inc. (NASDAQ:HSIC) CEO Bradford C. Connett sold 4,036 shares of Henry Schein stock in a transaction that occurred on Wednesday, March 19th. The shares were sold at an average price of $71.15, for a total transaction of $287,161.40. Following the transaction, the chief executive officer now directly owns 62,688 shares in the company, valued at $4,460,251.20. This represents a 6.05 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.

Henry Schein Price Performance

Shares of NASDAQ HSIC traded down $0.39 during mid-day trading on Thursday, hitting $70.45. 1,151,604 shares of the company’s stock traded hands, compared to its average volume of 1,506,691. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82. Henry Schein, Inc. has a 1 year low of $63.67 and a 1 year high of $82.49. The company’s 50-day moving average is $74.84 and its two-hundred day moving average is $72.62. The company has a market capitalization of $8.75 billion, a P/E ratio of 28.99, a PEG ratio of 2.13 and a beta of 0.90.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings results on Tuesday, February 25th. The company reported $1.19 EPS for the quarter, missing analysts’ consensus estimates of $1.23 by ($0.04). Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The business had revenue of $3.19 billion during the quarter, compared to the consensus estimate of $3.25 billion. During the same period in the previous year, the business posted $0.66 EPS. The firm’s revenue was up 5.8% on a year-over-year basis. On average, equities analysts anticipate that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in HSIC. Invesco Ltd. increased its position in Henry Schein by 0.4% during the fourth quarter. Invesco Ltd. now owns 4,963,409 shares of the company’s stock valued at $343,468,000 after acquiring an additional 17,552 shares during the last quarter. FMR LLC lifted its holdings in shares of Henry Schein by 6.6% in the 4th quarter. FMR LLC now owns 3,498,033 shares of the company’s stock worth $242,064,000 after acquiring an additional 217,143 shares during the last quarter. Geode Capital Management LLC boosted its stake in shares of Henry Schein by 0.5% during the 4th quarter. Geode Capital Management LLC now owns 3,169,033 shares of the company’s stock worth $218,762,000 after purchasing an additional 14,876 shares during the period. Palestra Capital Management LLC purchased a new position in Henry Schein during the 4th quarter valued at about $182,988,000. Finally, Southpoint Capital Advisors LP raised its holdings in shares of Henry Schein by 30.0% in the 3rd quarter. Southpoint Capital Advisors LP now owns 2,600,000 shares of the company’s stock valued at $189,540,000 after purchasing an additional 600,000 shares in the last quarter. Institutional investors own 96.62% of the company’s stock.

Analyst Upgrades and Downgrades

HSIC has been the topic of several analyst reports. UBS Group lowered their price target on shares of Henry Schein from $83.00 to $80.00 and set a “neutral” rating on the stock in a report on Wednesday, February 26th. Mizuho began coverage on shares of Henry Schein in a report on Wednesday, December 4th. They issued a “neutral” rating and a $75.00 target price on the stock. Jefferies Financial Group boosted their target price on shares of Henry Schein from $77.00 to $80.00 and gave the stock a “hold” rating in a report on Thursday, January 23rd. Wells Fargo & Company began coverage on shares of Henry Schein in a report on Friday, February 14th. They set an “equal weight” rating and a $80.00 price objective for the company. Finally, Bank of America upgraded Henry Schein from an “underperform” rating to a “buy” rating and raised their price objective for the company from $69.00 to $84.00 in a research report on Monday, January 6th. Six research analysts have rated the stock with a hold rating, five have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, Henry Schein presently has a consensus rating of “Moderate Buy” and a consensus price target of $81.10.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.